Induced Abortion in the Midtrimester in Adolescents and Young Women at the Department of Ob&Gyn at University Clinical Center Tuzla
DOI:
https://doi.org/10.5457/ams.v39i2.135Keywords:
adolescents, young women, abortion, laminariaAbstract
Between March 2008 and November 2009, we carried out a prospective study among adolescent and young women (14 - 24 years old) terminating a pregnancy at 13-23 weeks of gestation at Department of Ob&Gyn at University Clinical Center Tuzla. A total of 31 women were included into the study. The women were categorized into two groups: the study group of those who had procedure with application of laminaria alone (N=18) and the control group of those who had preparation with Pg gel in addition (N=13). We analyzed the age, parity, gestational age, the time between application of laminaria and the start of abortion, indications for abortion, risks and complications. The average age of women was 20.0 years ±2.8 and most of the patients were nuliparus (77.5%). In the study group the average age of women was 20.0 ± 2.7 and the most of the patient were nuliparus (72.2%). In the control group the average age of the women was 20.0±2.9 and most of the patient were nuliparus (84.6%).The indications for abortion were: fetal anomaly (19.3%), maternal disease (9.7%), miscarriage (16.0%), PPROM (13.0%) and artificial abortion (42.0%). Average length of procedure since applications of laminaria or Pg gel untill the end of abortion was 45 ±31.01_hours. In the study group the average length of procedure since application of laminaria until the end of abortion was 38 ± 24.6 hours. In the control group the average length of procedure since application of Pg gel till the end was 56 ± 33.8 hours. We did not have any complications in the study and control groups. We did not observe any significant side affects during or after the procedure.
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
